Hot Topics 2026: Diabetes, Menopause, Urology, Dermatology & Cardiometabolic Health (Manchester)
This meeting has been organised by CliniLink Ltd and is supported by the pharmaceutical industry via the purchase of exhibition stands. The sponsoring companies have had no involvement in the development of the agenda or content of this meeting.
Further information about the sponsorship can be found below.
See Sponsors below
£0.00
FACE TO FACE EVENT
THIS EVENT IS OPEN TO UK REGISTERED HEALTHCARE PROFESSIONALS ONLY
Location: Royal Nawaab Stockport Pyramid Yew Street
Event Agenda
| Time | Topic | Speaker |
|---|---|---|
| 09:00-09:20 | Registration & Refreshments | |
| 09:20-09:30 | Introduction and welcome | |
| 09:30-09:50 | What’s Hot in Diabetes | TBC |
| 09:50–10:50 | Case Study: Diabetes Optimisation | TBC |
| 10:50–11:20 | Break | |
| 11:20–11:50 | Prostate Cancer & Cardiometabolic Risk | TBC |
| 11:50–12:20 | Urology: ACB Score | TBC |
| 12:20–13:20 | LUNCH | |
| 13:20–14:20 | Obesity & MASLD | TBC |
| 14:20–15:20 | How Menopause Affects CVRM & Dermatology | TBC |
| 15:20–15:30 | Break | |
| 15:30–16:00 | Case Study: Lipids |
Study Day Summary
This dynamic, CPD-accredited study day brings together leading experts in diabetes, urology, oncology, metabolic medicine, and women's health to explore the conditions that increasingly intersect in everyday primary care practice. With a focus on practical, evidence-based learning, delegates will leave equipped with clinical skills and confidence to apply directly to their patients.
The day covers essential topic areas:
- Diabetes in practice – the latest developments in type 2 diabetes care, with case-based learning on treatment optimisation and individualised therapy
- Urology and men's health – the link between prostate cancer and cardiometabolic risk, and practical use of the anticholinergic burden (ACB) score in urological prescribing
- Obesity and MASLD – identifying and managing metabolic dysfunction-associated steatotic liver disease in patients living with obesity
- Menopause and cardiometabolic health – how menopause affects cardiovascular, renal, and metabolic risk and the skin, plus case-based lipid management
Learning Outcomes
By the end of this study day, participants will be able to:
- Describe the latest developments in type 2 diabetes management and apply case-based approaches to optimising therapy, addressing cardiovascular, renal, and metabolic risk rather than glucose alone
- Recognise the relationship between prostate cancer, its treatments, and cardiometabolic risk, and support safe monitoring and management of these patients in primary care
- Apply the anticholinergic burden (ACB) score to urological prescribing, identifying patients at risk and making safer medication choices
- Identify patients with obesity at risk of MASLD, use appropriate assessment and non-invasive testing, and follow evidence-based management and referral pathways
- Explain the impact of menopause on cardiovascular, renal, metabolic, and dermatological health, and apply structured, case-based approaches to lipid management in practice
Key Benefits
- Practical, clinically relevant content delivered by specialist speakers with primary care expertise
- Peer discussion and networking in a collaborative learning environment
- CPD-accredited certificate for revalidation portfolios
Additional Information
- This is a face-to-face, CPD-accredited event
- A certificate of attendance will be issued for full participation
- Suitable for GPs, prescribing pharmacists, nurses, and wider primary care MDT members